Malak Alaboudi
Neurology · Cleveland, OHNPI 1487323457
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations.
Across 156 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$566
- AstraZeneca$480
- Novartis$443
- EMD Serono, Inc.$253
- Genentech USA, Inc.$233
- Pfizer$149
- plus $932 from 18 others
What the payments were for
- Food & beverage$3,058100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 23 | $566 |
| AstraZeneca(2 entities) | 20 | $480 |
| Novartis | 27 | $443 |
| EMD Serono, Inc. | 17 | $253 |
| Genentech USA, Inc. | 13 | $233 |
| Pfizer | 10 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $148 |
| Jazz Pharmaceuticals Inc. | 7 | $127 |
| Averitas Pharma Inc. | 5 | $110 |
| Lilly USA, LLC | 4 | $74 |
| Amgen(2 entities) | 4 | $65 |
| Alnylam Pharmaceuticals Inc. | 2 | $62 |
| Lundbeck LLC | 3 | $60 |
| Sanofi | 3 | $57 |
| CSL Behring | 2 | $39 |
| Argenx US, Inc. | 1 | $35 |
| AbbVie | 2 | $30 |
| SK Life Science, Inc. | 1 | $21 |
| TG Therapeutics, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Biogen | 1 | $17 |
| Amylyx Pharmaceuticals, Inc. | 1 | $17 |
| Tanabe Pharma America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$111
How this compares
$3,058 in reported general payments places this provider in the 60th percentile of 702 neurology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 11 | $263 |
Paid to pharmacies, not to this prescriber.
Other neurology in Cleveland
- Imad NajmCleveland$373K
- Hesham AbboudCleveland$363K
- Robert BermelCleveland$302K
- Eric BaronCleveland$297K
- Robert FoxCleveland$296K
- Aarushi SunejaCleveland$269K
- Mary WillisCleveland$254K
- Benjamin WalterCleveland$210K
- Aasef ShaikhCleveland$186K
- Maryann MaysCleveland$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.